Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 16/20 | 0.41 |
| ▸ | SPR | P35270 | 2/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10181235 | 0.90 | EGLN1 (0.41) | EGLN1SPR | |
| SCHEMBL1578026 | 0.84 | EGLN1 (0.41) | EGLN1 | |
| SCHEMBL10180121 | 0.84 | EGLN1 (0.41) | EGLN1GAA | |
| SCHEMBL10179150 | 0.82 | DDB1 (0.48) | GAA | |
| SCHEMBL14142288 | 0.79 | MAPT (0.39) | EGLN1GAA | |
| SCHEMBL1577922 | 0.77 | GPR119 (0.45) | EGLN1 | |
| SCHEMBL1577753 | 0.74 | KDM4E (0.42) | EGLN1 | |
| SCHEMBL10181204 | 0.72 | DDB1 (0.48) | GAA | |
| SCHEMBL10180087 | 0.72 | CCR2 (0.38) | — | |
| SCHEMBL15972489 | 0.72 | MAPK1 (0.40) | EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120245344-A1 | GPR119 AGONIST | NIPPON CHEMIPHAR CO., LTD. (JP) | 2012-09-27 | — | — | US | disclosed |
| EP-2474540-A1 | GPR119 AGONIST | Nippon Chemiphar Co., Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245344-A1 | GPR119 AGONIST | GPR119, GPR4, GPR55 | EGLN1 1443/4885SPR 3618/4885GRM5 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.